Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia
1998

Study of p53 and DNA Changes in Oesophageal and Gastric Adenocarcinoma

Sample size: 60 publication Evidence: high

Author Information

Author(s): CM Gleeson, JM Sloan, DT McManus, P Maxwell, K Arthur, JA McGuigan, AJ Ritchie, SEH Russell

Primary Institution: The Queen's University of Belfast

Hypothesis

The study aims to investigate the association between 17p allelic loss, p53 gene mutation, p53 protein expression, and DNA aneuploidy in adenocarcinomas of the oesophagus and gastric cardia.

Conclusion

The study found similar patterns of p53 alterations in adenocarcinomas of the oesophagus and gastric cardia, indicating they may share a common aetiology.

Supporting Evidence

  • 79% of oesophageal adenocarcinomas showed 17p allelic loss.
  • 70% of oesophageal adenocarcinomas had p53 mutations.
  • 80% of oesophageal tumours were found to be DNA aneuploid.
  • 65% of oesophageal adenocarcinomas exhibited diffuse p53 protein expression.

Takeaway

This study looked at cancer samples from the esophagus and stomach to see if they had similar genetic changes, and they found that they did.

Methodology

The study involved tissue collection, DNA extraction, and analysis of p53 mutations and allelic loss using PCR and sequencing.

Limitations

The study did not find significant associations between genetic abnormalities and tumor stage or histological subtype.

Participant Demographics

The mean age at diagnosis for oesophageal adenocarcinoma was 61 years, with a male-female ratio of 17:3; for gastric cardia adenocarcinoma, the mean age was 63 years, with a male-female ratio of 31:10.

Statistical Information

P-Value

0.02

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication